Frontage Holdings (HKG:1521) posted a net profit of $2.9 million for the first quarter, compared with a net loss of $900,000 million a year earlier, according to a Tuesday Hong Kong bourse filing.
Shares of the biotech firm were up over 2% in Wednesday morning trade.
Revenue rose 19% to $67.9 million from $57.1 million in the prior-year period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.